Cargando…
Convergent TP53 loss and evolvability in cancer
Cancer cell populations evolve by a stepwise process involving natural selection of the fittest variants within a tissue ecosystem context and as modified by therapy. Genomic scrutiny of patient samples reveals an extraordinary diversity of mutational profiles both between patients with similar canc...
Autores principales: | Mansur, Marcela Braga, Greaves, Mel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518978/ https://www.ncbi.nlm.nih.gov/pubmed/37743495 http://dx.doi.org/10.1186/s12862-023-02146-6 |
Ejemplares similares
-
Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts
por: Burt, E C, et al.
Publicado: (2000) -
TP53 loss creates therapeutic vulnerability in colorectal cancer
por: Liu, Yunhua, et al.
Publicado: (2015) -
TP53: an oncogene in disguise
por: Soussi, T, et al.
Publicado: (2015) -
TP53 in Myelodysplastic Syndromes
por: Jiang, Yan, et al.
Publicado: (2021) -
Alterations of the TP53 Gene in Gastric and Esophageal Carcinogenesis
por: Bellini, Marilanda Ferreira, et al.
Publicado: (2012)